Group 1 - The company, MicroGuide Nano, announced the establishment of a special account for the proceeds from the issuance of convertible bonds [2] - The board of directors approved the proposal to set up a dedicated account for the management of raised funds and signed a fund supervision agreement [2] - The management team is authorized to handle the opening of the special account and the signing of the supervision agreement [2] Group 2 - The company signed a tripartite supervision agreement with its sponsor, CITIC Securities, and the commercial banks holding the raised funds [2] - This initiative aims to standardize the management and use of raised funds, ensuring the protection of investor rights [2]

广东科翔电子科技股份有限公司 募集资金管理制度 广东科翔电子科技股份有限公司 （2025 年 8 月修订） 第一章 总则 第一条 为规范广东科翔电子科技股份有限公司（以下简称"公司"）募集资 金管理，提高募集资金使用效率，根据《中华人民共和国公司法》《上市公司募 集资金监管规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上 市公司规范运作》等相关法律、法规和规范性文件以及《广东科翔电子科技股份 有限公司章程》（以下简称《公司章程》）的规定，制定本制度。 第二条 本制度适用于公司通过发行股票或者其他具有股权性质的证券，向 投资者募集并用于特定用途的资金监管，但不包括公司为实施股权激励计划募集 的资金监管。 第三条 募集资金到位后，公司应及时办理验资手续，并按照招股说明书或 者公开发行募集文件所承诺的募集资金使用计划，组织募集资金的使用工作。 第四条 募集资金应当专款专用。公司使用募集资金应当符合国家产业政策 和相关法律法规，践行可持续发展理念，履行社会责任，原则上应当用于主营业 务，有利于增强公司竞争能力和创新能力。 第五条 公司董事会应当持续关注募集资金存放、管理和使用情况，有效防 范投资风险， ...

Meeting Details - The fifth board meeting of Shenzhen Changliang Technology Co., Ltd. was convened on August 14, 2025, with all 9 directors present, meeting the legal requirements for quorum [1] - The meeting was chaired by Chairman Wang Changchun, with supervisors and senior management in attendance [1] Resolutions Passed - The board approved the 2025 semi-annual report and its summary, confirming that the report complies with legal and regulatory requirements and accurately reflects the company's situation [1][2] - The board agreed on the adequacy of the asset impairment provisions, stating that this will provide a more objective and fair representation of the company's asset status [2][3] - The board confirmed that the management of raised funds complies with relevant regulations and accurately reflects the status of fund usage in the semi-annual report [2][3] Cash Management - The board approved the use of idle raised funds and self-owned funds for cash management, emphasizing that this decision aligns with regulatory requirements and will enhance fund efficiency and returns for the company and its shareholders [4]

Core Points - The company held its ninth board meeting on August 14, 2025, with all seven directors present, complying with relevant laws and regulations [1][2][3] - The board approved the 2025 semi-annual report and its summary, which is available on the designated information disclosure website [1] - The board confirmed that the company has adhered to regulations regarding the storage and use of raised funds, with no violations reported [2] - The board agreed to cancel a total of 1,208,445 stock options from the 2022 stock option incentive plan that had been granted but not exercised [2][3]

Meeting Overview - The fifth meeting of the Supervisory Board of Shenzhen Changliang Technology Co., Ltd. was convened on August 10, 2025, and held on August 14, 2025, with all three supervisors participating, meeting legal requirements [1][2]. Supervisory Board Resolutions - The Supervisory Board approved the 2025 Half-Year Report and its summary, confirming that the report accurately reflects the company's actual situation without any false records or misleading statements [1][2]. - The Supervisory Board reviewed the special report on the storage and use of raised funds for the first half of 2025, concluding that the company complied with relevant regulations and that the report accurately reflects the situation without any violations [2][3]. - The decision to use idle raised funds and self-owned funds for cash management was deemed compliant with regulations, aimed at improving fund efficiency and returns for the company and shareholders, without harming the interests of minority shareholders [3][4].

Core Points - The report details the fundraising and usage status of Shenzhen Xinhau Optoelectronics Technology Co., Ltd. for the first half of 2025, ensuring compliance with relevant regulations and accurate disclosure of information [1][4][5] Fundraising Overview - The company raised a total of RMB 1,976 million by issuing 20 million new shares at a price of RMB 98.80 per share, with a net amount of RMB 1,895 million after deducting issuance costs [1][3] - The company has established a special account system for the management of the raised funds [1][4] Fund Usage - As of June 30, 2025, the company has used RMB 56.93 million of the raised funds, primarily for the electronic product glass protective screen project [10][12] - The company has temporarily used RMB 28.85 million of idle raised funds to supplement working capital, with plans to return the funds to the special account before the deadline [12][18] - The remaining balance of unused raised funds is RMB 525.17 million, with RMB 455 million allocated for cash management [3][12] Fund Management - The company has signed tripartite and quadripartite supervision agreements with various banks and its sponsor to ensure proper management of the raised funds [5][6] - The company has established a management system for the raised funds in accordance with relevant laws and regulations [4][5] Changes in Fund Investment Projects - The company has made adjustments to the investment amounts and project implementation entities, including increasing the investment in its subsidiary, Enshi Xinhau, for the glass protective screen project [13][14] - The expected completion date for the glass protective screen project has been extended to December 2025 [17] Compliance and Disclosure - The company has complied with all relevant regulations regarding the use and disclosure of raised funds, with no violations reported [15][18]

广东科翔电子科技股份有限公司 截至 2025 年 6 月 30 日止 前次募集资金使用情况鉴证报告 前次募集资金使用情况鉴证报告 众会字(2025)第 10200 号 广东科翔电子科技股份有限公司全体股东： 我们审核了后附的广东科翔电子科技股份有限公司（以下简称"科翔股份"）截至 2025 年 6 月 30 日止的《前次募集资金使用情况的专项报告》。 一、管理层的责任 科翔股份管理层的责任是提供真实、合法、完整的相关资料，按照中国证券监督管理委 员会《监管规则适用指引——发行类第 7 号》及相关规定编制《前次募集资金使用情况的专 项报告》，并保证其内容真实、准确、完整，不存在虚假记录、误导性陈述或重大遗漏。 二、注册会计师的责任 我们的责任是在实施鉴证工作的基础上对《前次募集资金使用情况的专项报告》发表鉴 证意见。 三、工作概述 我们按照《中国注册会计师其他鉴证业务准则第 3101 号-历史财务信息审计或审阅以外 的鉴证业务》的规定执行了鉴证业务。该准则要求我们计划和实施鉴证工作，以对《前次募 集资金使用情况的专项报告》是否不存在重大错报获取合理保证。在鉴证过程中，我们实施 了包括了解、询问、检查、重新计算， ...

募集资金管理制度 第一章 总则 第一条 为规范美盈森集团股份有限公司（以下简称"公司"）募集资金的存放、使 用和管理，保证募集资金的安全，提高募集资金使用效率，根据《中华人民共和国公司 法》《中华人民共和国证券法》《上市公司证券发行管理办法》《深圳证券交易所股票 上市规则》）（以下简称"股票上市规则"）、《深圳证券交易所上市公司自律监管指 引第 1 号——主板上市公司规范运作》《上市公司募集资金监管规则》等法律、法规及 规范性文件的规定及《美盈森集团股份有限公司章程》（以下简称"公司章程"），结 合公司实际情况，特制定本制度。 第二条 本制度所称募集资金，是指公司通过发行股票或者其他具有股权性质的证券， 向投资者募集并用于特定用途的资金。 本制度所称超募资金是指实际募集资金净额超过计划募集资金金额的部分。 第三条 募集资金到位后，公司应及时办理验资手续，由会计师事务所审验并出具验 资报告。公司对募集资金的管理遵循专户存放、规范使用、如实披露、严格管理的原则。 第四条 公司董事会负责建立健全募集资金管理制度，确保本制度的有效实施，及时 披露募集资金的使用情况，做到募集资金使用的公开、透明和规范。 第五条 公司应 ...

证券代码：001367 证券简称：海森药业 公告编号：2025-037 浙江海森药业股份有限公司 第三届监事会第十三次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 具体内容详见公司同日刊登在《证券时报》 《证券日报》 《上海证券报》和巨 （公告编号：2025- 潮资讯网（www.cninfo.com.cn）上的《2025年半年度报告摘要》 表决情况：3票同意，0票反对，0票弃权，审议通过了该议案。 的议案》 经核查，监事会认为：公司2025年半年度募集资金存放与使用情况符合《上 市公司募集资金监管规则》 一、监事会会议召开情况 浙江海森药业股份有限公司（以下简称"公司"）于2025年8月2日以钉钉及 电话通知的方式向全体监事发出了关于召开第三届监事会第十三次会议的通知， 会议于2025年8月13日在公司会议室以现场方式召开。本次会议由监事会主席韦 闯凡先生主持，应出席监事3名，实际出席监事3名，公司董事会秘书列席了本次 会议。本次会议的召集和召开符合《公司法》《公司章程》等有关规定，会议合 法、有效。 二、监事会会议审议情况 经核查，监事会认为 ...

证券代码：300629 证券简称：新劲刚 公告编号：2025-045 广东新劲刚科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、募集资金情况概述 经中国证券监督管理委员会《关于同意广东新劲刚科技股份有限公司向特定 对象发行股票注册的批复》（证监许可〔2023〕2808 号），广东新劲刚科技股 份有限公司（以下简称"公司"）获准向特定对象发行人民币普通股股票 事务所（特殊普通合伙）已于 2023 年 12 月 27 日对本公司向特定对象发行股票 的资金到位情况进行了审验，并出具了容诚验字[2023]510Z0023 号《验资报告》。 二、募集资金专户开立及监管协议签订情况 为规范公司募集资金管理，保护投资者权益，根据有关法律法规及《深圳证 券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》的规定， 作为募投项目实施主体的全资子公司广东宽普科技有限公司（以下简称"宽普科 技"）根据生产经营情况和募集资金项目投资需要，设立了募集资金专项账户。 乙方：交通银行股份有限公司佛山分行（以下简称乙方） 丙方：民生证券股份有限公司（以下简 ...